Imaging techniques valuable in glaucoma diagnosis

Article

Data from the ongoing European Optic Disc Assessment Trial (EODAT) indicated that imaging techniques could be valuable assets to ophthalmologists in the diagnosis of glaucoma, according to Nic Reus, MD, from the Glaucoma Service of The Rotterdam Eye Hospital, Rotterdam, The Netherlands.

Data from the ongoing European Optic Disc Assessment Trial (EODAT) indicated that imaging techniques could be valuable assets to ophthalmologists in the diagnosis of glaucoma, according to Nic Reus, MD, from the Glaucoma Service of The Rotterdam Eye Hospital, Rotterdam, The Netherlands.

"Glaucoma can be difficult to diagnose," Dr. Reus said. "The IOP may not be elevated in up to 50% of patients, and up to 50% of retinal ganglion cells may be lost early in the disease process."

The EODAT was designed to determine the accuracy and repeatability of European ophthalmologists in classifying stereoscopic optic disc photographs as healthy or glaucomatous and to compare their accuracy with that of GDxVCC (Carl Zeiss Meditec) and the Heidelberg Retina Tomograph (Heidelberg Engineering).

Stereoscopic optic disc photographs from 48 patients with glaucoma and 40 healthy individuals were evaluated. Sixteen photographs of healthy and glaucomatous eyes were duplicated for assessing intraobserver agreement, expressed as kappa. A total of 207 ophthalmologists classified the disc photographs as normal or glaucomatous.

Dr. Reus reported that the overall accuracy of the ophthalmologists in correctly classifying the photographs was 80.8%. In comparison, the GDxVCC, Heidelberg Retina Tomography, and Heidelberg Retina Tomography with Moorfields regression analysis correctly classified the photographs 93.2%, 89.8%, and 86.4%, respectively.

"Classification appears better by imaging than by most ophthalmologists. Classification is difficult for ophthalmologists," Dr. Reus concluded. "There were large variations among ophthalmologists and among countries. Imaging techniques appear to be better on average than ophthalmologists and these imaging techniques can be helpful to ophthalmologists in the diagnosis of glaucoma."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Related Content
© 2025 MJH Life Sciences

All rights reserved.